Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Publication Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingCertara2020 年 1 月 17 日
Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population Poster Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population Certara2019 年 6 月 24 日
Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV Poster Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV Certara2019 年 6 月 24 日
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Publication A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole Certara2018 年 7 月 1 日
Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Publication Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children Certara2018 年 6 月 4 日
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Certara2018 年 4 月 9 日
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Certara2018 年 4 月 1 日
Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Publication Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Certara2018 年 4 月 1 日
Using a pharmacology to payer framework to support product development Blog Using a pharmacology to payer framework to support product development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…Certara2018 年 3 月 16 日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Certara2018 年 3 月 1 日